Tech Company Financing Transactions

OncoMyx Therapeutics Funding Round

OncoMyx Therapeutics secured a $25 million Series A investment round on 6/6/2019. Investors included Boehringer Ingelheim Venture Fund, Delos Capital and Xeraya Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
OncoMyx plans to use the proceeds to advance development of its lead oncolytic virus (OV) therapeutic program for the treatment of various cancers.

Company Information

Company Status
Private & Independent
Mailing Address
445 N. 5th St.
Phoenix, AZ 85004
Email Address
OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement.
OncoMyx Therapeutics LinkedIn Company Profile
Social Media
OncoMyx Therapeutics Company Twitter Account
Company News
OncoMyx Therapeutics News
OncoMyx Therapeutics on Facebook
OncoMyx Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Steve Potts
  Steve Potts LinkedIn Profile  Steve Potts Twitter Account  Steve Potts News  Steve Potts on Facebook
Chief Operating Officer
Michael Wood
  Michael Wood LinkedIn Profile  Michael Wood Twitter Account  Michael Wood News  Michael Wood on Facebook
Chief Scientific Officer
Leslie Sharp
  Leslie Sharp LinkedIn Profile  Leslie Sharp Twitter Account  Leslie Sharp News  Leslie Sharp on Facebook
VP - R & D
Grant McFadden
  Grant McFadden LinkedIn Profile  Grant McFadden Twitter Account  Grant McFadden News  Grant McFadden on Facebook



Browse more venture capital transactions:

Prev: 6/6/2019: SentinelOne venture capital transaction
Next: 6/6/2019: Spiro venture capital transaction


Share this article


About Database of VC Transactions

We do our best to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary